Novartis Ag (NVS) Consolidated Net Income (2009 - 2026)
Novartis Ag's Consolidated Net Income came in at $3.26 billion for Q2 2026, down 19.1% from $4.02 billion a year earlier but up 3.2% from the prior quarter.
Novartis Ag (NVS) Consolidated Net Income (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Consolidated Net Income of $12.75 billion, down 6.5% year-over-year; for FY2025, it came in at $13.97 billion, up 17.0% from FY2024.
- Consolidated Net Income carries a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
- Going back by year, Consolidated Net Income was $11.94 billion in FY2024 (-19.6%), $14.85 billion in FY2023 (+113.6%), $6.96 billion in FY2022 (-71.0%) and $24.02 billion in FY2021 (+197.6%).
- The five-year range for quarterly Consolidated Net Income is $1.47 billion (Q4 2022) to $16.31 billion (Q4 2021).
- Year-over-year, Consolidated Net Income has declined for three consecutive quarters, with growth averaging 6.1% over the last eight quarters.
- The fastest year-over-year change in Consolidated Net Income over five years came in Q4 2021 (growth of 676.8%), and the weakest in Q4 2022 (a decline of 91.0%).
- Business Quant data shows NVS's Consolidated Net Income at $3.16 billion (Q1 2026), $2.4 billion (Q4 2025) and $3.93 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Bn |
| Mar 31, 2026 | 3.16 Bn |
| Dec 31, 2025 | 2.40 Bn |
| Sep 30, 2025 | 3.93 Bn |
| Jun 30, 2025 | 4.02 Bn |
| Mar 31, 2025 | 3.61 Bn |
| Dec 31, 2024 | 2.82 Bn |
| Sep 30, 2024 | 3.19 Bn |
| Jun 30, 2024 | 3.25 Bn |
| Mar 31, 2024 | 2.69 Bn |
| Dec 31, 2023 | 8.48 Bn |
| Sep 30, 2023 | 1.76 Bn |
| Jun 30, 2023 | 2.32 Bn |
| Mar 31, 2023 | 2.29 Bn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 1.58 Bn |
| Jun 30, 2022 | 1.70 Bn |
| Mar 31, 2022 | 2.22 Bn |
| Dec 31, 2021 | 16.31 Bn |
| Sep 30, 2021 | 2.76 Bn |
Novartis Ag Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=NVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();